Dr.Olive Launches Innovative Diet Supplement 'Ollypine' on Wadiz... Introducing a Bromelain-Enhanced Formula to Improve Olive Oil Bioavailability

Dr.Olive (CEO Gunu Lee) announced the official launch of its new dietarysupplement, 'Ollypine', which will be introduced for the first time through a Wadiz crowdfunding campaign scheduled to run from late October to early November. Ollypine is formulated with premium Spanish extra virgin olive oil combined with bromelain-an enzyme derived from pineapple-offering a scientifically driven solution aimed at enhancing the body's absorption and utilization of nutrition, presenting a new paradigm in the Korean Mediterranean diet market.

Product Launch

The Mediterranean diet has long been recognized globally for its health benefits, with olive oil at its core. Dr.Olive has reinterpreted this essential ingredient to suit the physiological characteristics and lifestyle patterns of Korean consumers. Ollypine is being publicly unveiled for the first time via Wadiz, marking the beginning of consumer-driven validation supported by exclusive early-bird rewards and limited-edition packages.

Key Technology and Differentiators

Ollypine is designed in capsule form to address the inconvenience and absorption limitations of traditional liquid olive oil formats. The key differentiating ingredient, bromelain, is known to maintain active enzymatic function within the gastrointestinal tract and facilitate the breakdown of lipids. According to scientific research, bromelain may significantly improve the digestive process and bioavailability of beneficial fatty acids and polyphenols found in extra virgin olive oil. This enhanced absorption mechanism allows consumers to efficiently experience the full health benefits of olive oil with just two capsules per day.

Market Outlook and Leadership Statement

"Ollypine represents a true 'Korean-style Mediterranean diet solution,' specifically optimized for modern dietary habits and the metabolic profile of Korean consumers," said Gunu Lee, CEO of Dr.Olive. "Rather than being just another diet supplement, Ollypine is designed to enhance core bioavailability and health efficacy. Our Wadiz launch marks the first step toward expanding into global health and wellness markets."

Future Plans and Consumer Information

The Ollypine Wadiz campaign is set to begin in late October and will run for approximately two weeks. The campaign will gradually reveal detailed information on the product's formulation, bromelain-based absorption mechanism, and scientific comparison data. Early participants will be granted exclusive benefits. With this launch, Dr.Olive aims to establish a strong presence in the global diet and healthcare market.

Media Contact:
Gunu Lee
Lumiel
Saeromnam-ro
Sejong Special Self-Governing City
Korea, Republic of
guu14097@gmail.com
https://www.drolive.kr/

Company Overview

Dr.Olive is a healthcare brand specializing in research and development of olive oil-based nutritional solutions focused on improving bioavailability and maximizing functional efficacy. Guided by the philosophy, "The answer lies in nature," Dr.Olive is committed to delivering scientifically driven Mediterranean diet solutions tailored for the global market, starting from Korea.

This release was published on openPR.